DOE Patents title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Compositions and methods that promote hypoxia or the hypoxia response for treatment and prevention of mitochondrial dysfunction and oxidative stress disorders

Abstract

Methods of promoting hypoxia or the hypoxia response for the treatment or prevention of mitochondrial dysfunction and oxidative stress disorders are described. Methods for screening for targets of mitochondrial dysfunction and oxidative stress disorders are also described.

Inventors:
; ; ;
Issue Date:
Research Org.:
The General Hospital Corp., Boston, MA (United States); Massachusetts Inst. of Technology (MIT), Cambridge, MA (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1771657
Patent Number(s):
10842812
Application Number:
15/751,585
Assignee:
The General Hospital Corporation (Boston, MA); MASSACHUSETTS INSTITUTE OF TECHNOLOGY (Cambridge, MA)
Patent Classifications (CPCs):
A - HUMAN NECESSITIES A61 - MEDICAL OR VETERINARY SCIENCE A61K - PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
A - HUMAN NECESSITIES A61 - MEDICAL OR VETERINARY SCIENCE A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
DOE Contract Number:  
FG02-97ER25308
Resource Type:
Patent
Resource Relation:
Patent File Date: 08/12/2016
Country of Publication:
United States
Language:
English

Citation Formats

Mootha, Vamsi K., Jain, Isha, Zapol, Warren M., and Zazzeron, Luca. Compositions and methods that promote hypoxia or the hypoxia response for treatment and prevention of mitochondrial dysfunction and oxidative stress disorders. United States: N. p., 2020. Web.
Mootha, Vamsi K., Jain, Isha, Zapol, Warren M., & Zazzeron, Luca. Compositions and methods that promote hypoxia or the hypoxia response for treatment and prevention of mitochondrial dysfunction and oxidative stress disorders. United States.
Mootha, Vamsi K., Jain, Isha, Zapol, Warren M., and Zazzeron, Luca. Tue . "Compositions and methods that promote hypoxia or the hypoxia response for treatment and prevention of mitochondrial dysfunction and oxidative stress disorders". United States. https://www.osti.gov/servlets/purl/1771657.
@article{osti_1771657,
title = {Compositions and methods that promote hypoxia or the hypoxia response for treatment and prevention of mitochondrial dysfunction and oxidative stress disorders},
author = {Mootha, Vamsi K. and Jain, Isha and Zapol, Warren M. and Zazzeron, Luca},
abstractNote = {Methods of promoting hypoxia or the hypoxia response for the treatment or prevention of mitochondrial dysfunction and oxidative stress disorders are described. Methods for screening for targets of mitochondrial dysfunction and oxidative stress disorders are also described.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {Tue Nov 24 00:00:00 EST 2020},
month = {Tue Nov 24 00:00:00 EST 2020}
}

Works referenced in this record:

Inhaled Nitric Oxide and Persistent Pulmonary Hypertension of the Newborn
journal, February 1997


Mitochondrial Disease: A Practical Approach for Primary Care Physicians
journal, November 2007


Mitochondrial disorders as windows into an ancient organelle
journal, November 2012


Leigh Syndrome Mouse Model Can Be Rescued by Interventions that Normalize Brain Hyperoxia, but Not HIF Activation
journal, October 2019


A modern approach to the treatment of mitochondrial disease
journal, October 2009


Response Time of Pulse Oximeters Assessed Using Acute Decompression
journal, January 1992


Hypobaric Hypoxia Imbalances Mitochondrial Dynamics in Rat Brain Hippocampus
journal, January 2015


Visible Light Modulation of Mitochondrial Function in Hypoxia and Disease
patent-application, October 2013


Assays, Methods and Means
patent-application, October 2014


Stable hypoxia inducible factor-1 alpha and method of use
patent-application, September 2003


Inspiratory Synthesis of Nitric Oxide
patent-application, February 2016


Mitochondrial disorders
journal, September 2004


Methods, Compositions and Articles of Manufacture for HIF Modulating Compounds
patent-application, November 2012


Inhaled Nitric Oxide for the Adult Respiratory Distress Syndrome
journal, February 1993


Physiological and Pathological Responses to Hypoxia
journal, June 2004


Targeting the von Hippel–Lindau E3 Ubiquitin Ligase Using Small Molecules To Disrupt the VHL/HIF-1α Interaction
journal, February 2012